Skip to main content

memantine

NDC 62135-895 · Chartwell RX, LLC

Generic namememantine
Dosage formTABLET
RouteORAL
Active ingredient(s)MEMANTINE HYDROCHLORIDE
Strength5 mg/1
Pharmacologic classN-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
Marketing categoryANDA

Packages

62135-895-60 — 60 TABLET in 1 BOTTLE (62135-895-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55154-7637 — Memantine Hydrochloride, 59651-404 — MEMANTINE HYDROCHLORIDE, 59651-405 — MEMANTINE HYDROCHLORIDE, 59651-406 — MEMANTINE HYDROCHLORIDE, 59651-407 — MEMANTINE HYDROCHLORIDE, 60505-6162 — memantine hydrochloride, 60687-173 — Memantine, 60687-184 — Memantine, 61442-192 — Memantine Hydrochloride, 61442-193 — Memantine Hydrochloride, 62135-896 — memantine, 62135-943 — Memantine Hydrochloride, 62332-075 — memantine hydrochloride, 62332-076 — memantine hydrochloride, 62559-207 — MEMANTINE AND DONEPEZIL HYDROCHLORIDES, 63629-2511 — Memantine Hydrochloride, 63629-2512 — Memantine Hydrochloride, 63629-2513 — Memantine Hydrochloride, 63629-2514 — Memantine Hydrochloride, 65162-169 — memantine, +115 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels